Mr Turki Almaslokh
(he/him)

Research student

Working on:

Investigating the risk factors, mechanism, and clinical biomarkers associted with Hydroxychloroquine (HCQ) retinal toxicity by using multimodal imaging including the multifocal electroretinogram, Spectral domain optical coherance tomography, Ootical coherance tomography angiography, and densitometry.

Experiance :

Lecturer & Optometrist (2019-Present): KSU, Riyadh, Saudi Arabia.
Optometrist (2018-2022): Private clinical Center.

Qualifications:

PhD (2024-Present): Retinal dosorders: Cardiff University, Cardiff, UK.
Fellowship (2023-2024): Educational Fellow ship: Cardiff University, Cardiff, UK.
Msc:(2022-2023): Clinical Optometry: Cardiff University, Cardiff, UK.
Myopia Control: Qualified Myopia Control (MYLO)
Bsc: (2013-17): Optometry Doctor: King Saud University (KSU), Riyadh, Saudi Arabia.

Interested in: Retinal disorder and glaucoma field.

A dedicated researcher specializing in the field of retinal disorders and glaucoma, with a keen interest in understanding the complexities of retinal health. The current focus is on investigating the toxicity of hydroxychloroquine on retinal structure and function. This research aims to uncover the potential impacts of this drug on the retina, contributing to improved patient care and safety in ophthalmology. The work is driven by a passion for advancing knowledge in retinal health and developing strategies to mitigate drug-induced retinal toxicity.